Your browser doesn't support javascript.
loading
Peripheral artery disease: an underdiagnosed condition in familial hypercholesterolemia? A systematic review.
Acitelli, Elisa; Guedon, Alexis F; De Liguori, Sara; Gallo, Antonio; Maranghi, Marianna.
Afiliação
  • Acitelli E; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Guedon AF; Département Hospitalo-Universitaire Inflammation Immunopathologie Biothérapie (DMUi3), Sorbonne Université, APHP, Service de Médecine Interne, Paris, France.
  • De Liguori S; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Gallo A; Department of Nutrition, APHP, Hôpital Pitié-Salpètriêre, Sorbonne Université, INSERM UMR1166, Lipidology and cardiovascular prevention Unit, 47/83 boulevard de l'Hôpital, F-75013, Paris, France.
  • Maranghi M; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. marianna.maranghi@uniroma1.it.
Endocrine ; 85(1): 122-133, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38457056
ABSTRACT

PURPOSE:

Familial hypercholesterolemia (FH) is one of the most common inherited diseases characterized by elevated LDL-cholesterol levels, leading to early-onset atherosclerosis. While the association between FH and coronary and carotid artery disease is well-established, its association with peripheral artery disease (PAD) is less robust. This systematic review aims at exploring existing evidence on PAD prevalence and incidence in FH individuals.

METHODS:

A comprehensive search was conducted on MEDLINE and Embase databases, for studies published between January 2013 and December 2023, evaluating prevalence and incidence of PAD in FH patients. Literature reviews, case reports, responses to editors and non-English language articles were excluded.

RESULTS:

The initial research provided 53 results. After article screening, 28 articles were fully reviewed and 24 were finally included in the analysis. Among these, 19 reported PAD prevalence, while 5 PAD incidence over a mean follow-up time of 8.7 years. PAD prevalence and incidence ranged from 0.3 to 60% and from 0.5 to 4.2% respectively, probably reflecting the heterogeneity in PAD definition criteria.

CONCLUSION:

This systematic review sheds light on the limited number of studies on PAD in FH patients. Particularly, considering the potential positive effects of newly available lipid-lowering strategies on PAD outcomes, addressing this research gap is pivotal for a more comprehensive understanding of peripheral vascular manifestations in FH patients and for optimal management of this population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Arterial Periférica / Hiperlipoproteinemia Tipo II Limite: Humans Idioma: En Revista: Endocrine Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Arterial Periférica / Hiperlipoproteinemia Tipo II Limite: Humans Idioma: En Revista: Endocrine Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália